TOP TIERMARKET NEWSWIRE
News & sentiment

NEWAMSTERDAM PHARMA (NAMS) — News & AI sentiment

NEWAMSTERDAM PHARMA (NAMS) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 48.2/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $227K and 3 sales totalling $4.7M — net selling of $4.4M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 48.2/100
Insider net (90d)
$4.4M
1 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

NAMS news in the last 24 hours, 7 days, 30 days and 90 days

How much NAMS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNAMS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days648.2/100NAMS headlines →
Last 90 days2654.5/100NAMS headlines →

Latest stories on NAMS

RBC Capital cuts NewAmsterdam Pharma stock price target on trial risk
Investing.com Analyst Ratings38 · neutralanalyst
Oct 5
Oct 5
Oct 2
Oct 2
Sep 29
Sep 29
Sep 23
Sep 21
Stifel reiterates NewAmsterdam Pharma stock rating on EU approval
Investing.com Analyst Ratings56 · neutralanalyst
Sep 21
Sep 21
Sep 21
NewAmsterdam Pharma stock rises as CEO buys $226.5K in stock
Investing.com Markets63 · neutralgeneral
Sep 15
Sep 8
Sep 8
Stifel reiterates Buy on NewAmsterdam Pharma stock after trial failure
Investing.com Analyst Ratings56 · neutralanalyst
Sep 8
Sep 3
Sep 2
Sep 2
Aug 26
Aug 14
Aug 9
Aug 6
Aug 5
Aug 5
Aug 5
Open NAMS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →